Razle-20 is a pharmaceutical tablet composed of Rabeprazole Tablet of 20mg. Rabeprazole Tablet is useful in the treatment of excess acid being produced inside the stomach leading to acid related diseases of stomach and intestine. This medicine is useful in the treatment of acid-related haelth issues such as gastroesophageal reflux disease or acid reflux, peptic ulcers, etc. Consuming Rabeprazole Tablet helps relax your stomach and reduce the amount of acid being produced.
Rabeprazole Tablet is effective in treating health conditions arising from excess acid production in the stomach. It is also useful for preventing stomach ulcers and acidity that may arise with prolonged use of painkillers. Rabeprazole Tablet belongs to the class of medicines called proton pump inhibitors (PPIs).
This medicine is an oral tablet and should be taken empty stomach. Follow the dosage and frequency as prescrbed by you doctor based on your medical condition and other related factors. Avoid changing the dosage or frequency on your own without consulting your doctor, this may hinder your pregress of treatment. Along with this medication, take steps to improve your lifestyle habits by bringing necessary changes.
Before taking Rabeprazole Tablet, tell your doctor if you ever had liver problems, HIV, allergic reactions, osteoporosis, etc. Tell your doctor if you are allergic to any component of Rabeprazole Tablet or any other allergy in general.
Where to get Rabeprazole Tablet?
Rabeprazole Tablet is available with Servocare Lifesciences under the brand name Razle-20. Servocare Lifesciences is well-known for the manufacturing, supply, and PCD Franchise of Rabeprazole Tablet. Servocare is equipped with the advanced technologies to manufacture the best quality of Rabeprazole Tablet while maintaing utmost efficiency in their operations.
Get the supply of top quality Rabeprazole Tablet from Servocare Lifesciences anywhere in India at the best ever prices. To avail of Rabeprazole Tablet manufacturing, supply, and PCD Franchise, get in touch with Servocare Lifesciences at the earliest.